{"id":8617,"date":"2026-03-13T13:30:06","date_gmt":"2026-03-13T13:30:06","guid":{"rendered":"https:\/\/godshand.link\/ground_post\/report-of-the-49th-meeting-of-the-who-global-advisory-committee-on-vaccine-safety-27-28-november-2025\/"},"modified":"2026-03-13T13:30:06","modified_gmt":"2026-03-13T13:30:06","slug":"report-of-the-49th-meeting-of-the-who-global-advisory-committee-on-vaccine-safety-27-28-november-2025","status":"publish","type":"ground_post","link":"https:\/\/godshand.link\/en_gb\/ground_post\/report-of-the-49th-meeting-of-the-who-global-advisory-committee-on-vaccine-safety-27-28-november-2025\/","title":{"rendered":"Report of the 49th meeting of the WHO Global Advisory Committee on Vaccine Safety, 27-28 November 2025"},"content":{"rendered":"<p><br \/>\n<\/p>\n<section class=\"dynamic-content__section dynamic-content__container\">\n<div class=\"dynamic-content__section-container\">\n<div class=\"dynamic-content__figure-container\">\n<figure class=\"dynamic-content__figure\">\n      <img decoding=\"async\" src=\"https:\/\/cdn.who.int\/media\/images\/default-source\/default-album\/screenshot_gacvs_report_202511.tmb-479v.png?sfvrsn=11294_1\" alt=\"Report of the 49th meeting of the WHO Global Advisory Committee on Vaccine Safety, 27-28 November 2025\"><br \/>\n     <\/figure>\n<\/p><\/div>\n<div class=\"dynamic-content__description-container\">\n<div class=\"row\">\n<div class=\"col-md-8\">\n<div class=\"dynamic-content__description\">\n<h3>Overview <\/h3>\n<p>The Global Advisory Committee on Vaccine Safety (GACVS) was established in 1999 as an independent expert advisory body to WHO on policies and issues related to vaccine safety. The 49th GACVS meeting, held in hybrid mode on 27\u201328 November 2025, brought together global experts to address a range of issues in vaccine safety. The key objective of the meeting was to provide updates and solicit feedback from GACVS members on key vaccine safety and policy issues that had been identified since the previous meeting of the Committee in May 2025. A summary of the presentations and recommendations is provided below. The next meeting of GACVS, a joint meeting with the Advisory Committee on Safety of Medicinal Products (ACSoMP), will take place in Geneva on 23\u201326 June 2026.<\/p>\n<div id=\"dynamic-content__accordion\" class=\"dynamic-content__accordion\">\n<p><a target=\"_blank\" href=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/40da10d3-7418-4017-9de1-22723675247b\/content\" data-sf-ec-immutable=\"\" data-sf-marked=\"\">Download<\/a><\/p>\n<\/p><\/div><\/div><\/div>\n<div class=\"col-md-4\">\n<div class=\"dynamic-content__details\">\n<div class=\"detail who-team\">\n<div class=\"label\">WHO Team<\/div>\n<div class=\"value\">\n                 <span><br \/>\nPharmacovigilance (PVG)                 <\/span>\n         <\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Editors<\/div>\n<div class=\"value\">World Health Organization<\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Number of pages<\/div>\n<div class=\"value\">6<\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Reference numbers<\/div>\n<div class=\"value\">\n<div><strong class=\"label-sm\">WHO Reference Number: <\/strong><span>Nos. 9\/10, 2026, 101, 37\u201342<\/span><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\n<\/section>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.who.int\/publications\/i\/item\/report-of-the-49th-meeting-of-the-who-global-advisory-committee-on-vaccine-safety--27-28-november-2025?rand=6398\" target=\"_blank\">Source link <\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Overview The Global Advisory Committee on Vaccine Safety (GACVS) was established in 1999 as an independent expert advisory body to WHO on policies and issues related to vaccine safety. The 49th GACVS meeting, held in hybrid mode on 27\u201328 November 2025, brought together global experts to address a range of issues in vaccine safety. The key objective of the meeting&hellip;<\/p>","protected":false},"author":99035,"featured_media":8618,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","format":"standard","meta":{"give_campaign_id":0,"footnotes":""},"tags":[2091,2092,1996,455,452,703,687,1990,995],"ground_category":[315,316],"class_list":["post-8617","ground_post","type-ground_post","status-publish","format-standard","has-post-thumbnail","hentry","tag-49th","tag-advisory","tag-committee","tag-global","tag-meeting","tag-november","tag-report","tag-safety","tag-vaccine","ground_category-2-grounds-tribulation","ground_category-2-1-time-disease"],"fifu_image_url":"https:\/\/cdn.who.int\/media\/images\/default-source\/default-album\/screenshot_gacvs_report_202511.tmb-479v.png?sfvrsn=11294_1","_links":{"self":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/8617","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post"}],"about":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/types\/ground_post"}],"author":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/users\/99035"}],"replies":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/comments?post=8617"}],"version-history":[{"count":0,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/8617\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media\/8618"}],"wp:attachment":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media?parent=8617"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/tags?post=8617"},{"taxonomy":"ground_category","embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_category?post=8617"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}